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Bovine jugular vein thrombosis in the Fontan circulation
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The bovine jugular vein (Contegra; Medtronic, Inc, Min-neapolis, Minn) is an alternative conduit for reconstruc-tion of the right ventricular outflow tract1 that also haspotentially attractive characteristics for use in the Fon-
tan circulation. We implanted this newly introduced conduit in 3
patients as an extracardiac connection between the inferior caval
vein and the pulmonary artery to complete the cavopulmonary
circulation. Their histories are described. All 3 patients had throm-
bosis develop in the conduit. The mechanism of this complication
remains to be elucidated. Two patients died, and the other had
neurologic damage. Use of the Contegra conduit in the Fontan
circulation is discouraged.
Clinical Summaries
PATIENT 1. A 7-year-old boy (body weight 20 kg) with dex-
trocardia, right atrial isomerism, unbalanced atrioventricular septal
defect, and discordant ventriculoarterial connections underwent a
bidirectional cavopulmonary anastomosis after previous pulmo-
nary artery banding. The Fontan circulation was completed with a
20-mm valved segment of bovine jugular vein (Contegra) im-
planted as an extracardiac conduit between a normal inferior caval
vein and the left pulmonary artery. Unobstructed flow through the
conduit was confirmed by intraoperative transesophageal echocar-
diography. Two days later, a 5-mm fenestration between the con-
duit and the atrium was created because of low cardiac output and
a high systemic venous pressure. Warfarin sodium was given as
antithrombotic prophylaxis, and the patient was discharged on day
9. Six months later, surgical reopening of the spontaneously closed
fenestration was planned because of unexplained protein-losing
enteropathy and progressive dyspnea on exertion. However, the
patient required urgent admission following discontinuation of the
anticoagulants because of evolving cardiac shock. Transthoracic
echocardiography revealed obstruction of the bovine conduit. Im-
mediate surgical revision was carried out, and a subtotal throm-
botic occlusion of the conduit was found (Figures 1 and 2).
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The bovine jugular conduit was replaced with a 20-mm fenes-
trated polytetrafluoroethylene*1 (PTFE) conduit. Microscopy con-
firmed that occlusion of the conduit was caused by thrombosis.
Although the absence of cellular ingrowth into the thrombus
prevented assessment of the exact age of the thrombus, its structure
indicated that its formation had evolved during a period of weeks.
The patient was extubated 10 days after the operation and antico-
agulants were resumed, but an acceptable international normalized
ratio was difficult to attain because of hepatic and renal dysfunc-
tion. Three weeks later, the patient died during surgical evacuation
of a cerebral hemorrhage.
PATIENT 2. A 3-year-old boy (12.5 kg) with tricuspid atresia,
concordant ventriculoarterial connections, and restrictive ventric-
ular septal defect had a previous modified right Blalock-Taussig
shunt followed by a bidirectional cavopulmonary anastomosis. He
underwent a total cavopulmonary connection created with a
14-mm valveless segment of bovine jugular vein as an extracardiac
conduit. A fenestration was created between the conduit and the
atrium. Unobstructed flow through the conduit was confirmed by
intraoperative transesophageal echocardiography. No anticoagu-
lants were given after the operation. Seven days later, symptoms of
discomfort and nausea preceded cyanosis and was followed by a
state of shock. Transthoracic echocardiography during resuscita-
tion provided no information on conduit patency. Cardiopulmo-
nary resuscitation including external cardiac massage was unsuc-
cessful. During resuscitation cyanosis persisted. At autopsy, large
thrombi were found to occlude both the right and left pulmonary
arteries, and thrombotic material was found adherent to the luminal
side of the conduit near the fenestration. On the basis of micros-
copy of the pulmonary thrombi, which showed focal organization,
the age of the thrombi was estimated to be 1 to 2 days. No thrombi
were found in the peripheral pulmonary arteries.
PATIENT 3. A 3-year-old boy (14 kg) with tricuspid atresia,
concordant ventriculoarterial connections, and pulmonary stenosis
underwent creation of a Blalock-Taussig shunt followed by a
bidirectional cavopulmonary anastomosis. The total cavopulmo-
nary connection was completed with an 18-mm valveless segment
of bovine jugular vein as an extracardiac conduit. A fenestration
was created between the conduit and the atrium. Unobstructed flow
through the conduit was confirmed echocardiographically. A few
hours after the patient’s arrival in the intensive care unit, low
cardiac output developed, associated with high systemic venous
pressures and cyanosis. Transthoracic echocardiography 5 hours
after the operation raised the suspicion of conduit obstruction. At
surgical revision, a subtotal occlusion of the conduit was found,
with the thrombus localized halfway through the prosthesis near
the fenestration.
A 16-mm PTFE conduit was used to replace the bovine con-
duit. During postoperative recovery, a left-sided hemiparesis with
aphasia and ataxia developed as a result of a parietal cerebral
infarction diagnosed on computed tomographic scan. At the latest
follow-up, minor left-sided hypertonia and facial paresis persisted.
Discussion
The use of the Contegra bovine jugular venous conduit for the final
stage Fontan operation is a conceivable step for the surgeon
accustomed to and satisfied with this conduit for reconstruction of
the right ventricular outflow tract. This step was made indepen-
dently in our country by two surgeons from two different institu-
tions, both of whom saw the same adverse outcome. Thrombosis
occurred in 1 patient who received antithrombotic prophylaxis. It
probably took weeks to evolve and started to cause symptoms
when the prophylaxis was stopped. In the second patient, who had
no antithrombotic prophylaxis, similar symptoms developed as
*Gore-Tex Stretch Vascular Graft, registered trademark of W. L. Gore &
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Figure 1. Explanted bovine jugular venous conduit opened longi-
tudinally to show mural thrombi and occlusive thrombotic mass.
Figure 2. Transverse section of specimen shows densely orga-
nized thrombus adjacent to conduit wall and fresh thrombus in
center.
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early as 7 days after the operation. Although most of the throm-
botic fragments were found in the large pulmonary arteries, the
observation of thrombotic deposits on the inner surface of the
conduit, the age of the thrombus (1 to 2 days), and the fact that
external heart massage had been applied led us to believe that the
conduit was the original source. In the third patient, the conduit
obstruction developed only a few hours after the operation. Be-
cause a peripheral source of thromboemboli is unlikely so early
after the operation, thrombus formation in the conduit is the most
plausible explanation. The unilateral cerebral infarction may be
attributed to a paradoxical thromboembolus through the fenestra-
tion.
In all 3 cases, the conduit fenestration may have played a role
in the origin of the thrombosis as a result of focally disturbed flow
patterns. Indeed, thrombus deposition was found near the fenes-
tration in both patients with a patent fenestration and was incor-
porating the site of the occluded fenestration in the first patient.
The valve of the conduit, which was found to be included within
the thrombus in the first patient, may also have been a site at risk
for thrombus formation.
We treated 23 other patients who were comparable in terms of
age, use of antithrombotic prophylaxis, and fenestration and who
also underwent a total cavopulmonary connection but with the use
of PTFE as an extracardiac conduit. Thrombosis did not occur in
any of these patients. The difference between no thrombotic events
in 23 patients (0%, 95% confidence interval 0%-15%) and 3
thrombotic events in 3 patients (100%, 95% confidence interval
29%-100%) in whom the bovine jugular vein was used is statisti-
cally significant (P  .001 by the Fisher exact test). There have
been no reports in the literature of conduit obstruction in the
Fontan circulation as a result of extensive thrombosis in properly
sized extracardiac conduits,2-5 so the major cause of thrombosis
must be related to the nature of the jugular bovine conduit itself,
associated with the local conditions of blood flow.
Pathologic data on prosthetic conduits used for extracardiac
construction of a total cavopulmonary connection do not exist.
Other prosthetic conduits, such as Dacron polyester fabric and
PTFE, and arterial allografts acquire a “neointima” after implan-
tation in the arterial circulation, which effectively establishes a
host-to-tissue compatibility that is important to prevent thrombo-
sis.6-8 A protective host endothelial coverage was absent in bovine
jugular venous explants after 6 months in the pulmonary position
in mongrel dogs. Explants instead showed an inflammatory reac-
tion in both the valve and the wall of the conduit, which was
associated with cuspal thrombus in 1 of the studied cases.9 This
lack of endothelial resurfacing and the inflammatory response,
both of which were attributed to the cytotoxicity of the applied
cross-linking agent glutaraldehyde, may explain the increased ten-
dency for thrombosis. In addition, the surface of this cytotoxic area
is large in the bovine jugular venous conduit relative to other
bioprosthetic valves, which may further add to thrombogenicity.
Both factors may be of limited importance in the high pulsatile
flow of the right ventricular outflow tract but could become critical
when flow is slow and nonpulsatile. If the cross-linking agent
glutaraldehyde is the cause of the observed thrombogenicity, re-
placing it with a less cytotoxic agent might allow increased
biocompatibility and endothelialization, with reduced thromboge-
nicity.
Conclusion
Obstructive thrombosis may occur in the Contegra bovine jugular
venous conduit used as an extracardiac conduit in the Fontan
circulation. We discourage the use of this conduit for this indica-
tion.
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